Lv3
330 积分 2024-09-19 加入
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
3小时前
求助中
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
1个月前
已完结
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906
2个月前
已完结
Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma
3个月前
已完结
Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial
4个月前
已关闭
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma
4个月前
已关闭
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
6个月前
已完结
Patient-Reported Outcomes From KATHERINE: A Phase 3 Study of Adjuvant Trastuzumab Emtansine Versus Trastuzumab in Patients with Residual Invasive Disease After Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
7个月前
已完结
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity
8个月前
已完结
皖公网安备34019202002308
